Guardant Health, Inc. vs Johnson & Johnson
GH vs JNJ — side-by-side comparison from reported financials. GH leads 2, JNJ leads 5 of 7 comparable metrics.
Guardant Health, Inc.
GH · Healthcare
$167.40+1.11%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | GH | JNJ |
|---|---|---|
| Price | $167.40 | $261.79 |
| Market cap | $22.5B | $631B |
| Revenue (TTM) | $1.18B | $97.9B |
| Revenue growth | +29.8% | +5.6% |
| Net margin | -38.3% | 21.5% |
| Free cash flow | -$241M | $22.2B |
| Net cash (debt) | — | ($27.8B) |
| 1-year price return | +156.5% | +37.0% |
| P/E | — | 29.9 |
| P/E vs own history (cheap-side %) | — | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | -247% | 26% |
| Altman Z-score | 4.47 | — |
| CV checks passed | 5 of 9 | 10 of 9 |
| Employees | 2,506 | 140,800 |
Full résumé-style profiles: GH CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.